Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by PLITheOneon Jul 22, 2022 11:02am
243 Views
Post# 34843074

RE:Surprise

RE:Surprise

Either through ignorance or satire you seem to be oblivious to the fact that these criminals unethically stole millions from the average retail investor!
Thomvest stole a 2.5 billion dollar company, destroying all potential to make it worth a few million. They are facing an almost $1 billion dollar lawsuit atm. Anyone who invests here is ignorant or looking for easy capital losses  


inventors wrote: That would be negative news, but best to know safery tolerance....?

There still seems to be scetchy info on Ryplazmin...lmnl own 30%...?

Mfg plant....?

The Antagonists switches...pre-clinical new indications...?

GPR84....?

OXER1...?

Clean shelf of a listed company. 15M cap and credit...perhaps today will be the new Bottom...?

Pierre performed better...?

 

<< Previous
Bullboard Posts
Next >>